These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 482193)

  • 1. Insulin immunology: humoral and cellular aspects in mono-component insulin treated patients.
    Devlin JG; Maguire O; Parameswaran V; Blake PJ
    Postgrad Med J; 1979; 55 Suppl 2():14-8. PubMed ID: 482193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals.
    Schernthaner G; Borkenstein M; Fink M; Mayr WR; Menzel J; Schober E
    Diabetes Care; 1983; 6 Suppl 1():43-8. PubMed ID: 6343038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin antibody production studied quantitatively with a modified radioimmunoassay technique and with radioimmunoelectrophoresis in patients treated with monocomponent (MC) insulin.
    Bruni B; Ricci C; Giolitti A; Osenda M; D'Alberto M; Turco GL
    J Nucl Biol Med; 1973; 17(3):123. PubMed ID: 4746315
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diabetes and immunology. III. Immunological reactions related to insulin treatment].
    Ekoe JM; Albert J
    Sem Hop; 1983 Jun; 59(23):1784-7. PubMed ID: 6308810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of monocomponent insulins and conventional insulins on the course of diabetic nephropathy. A follow-up study.
    Viswanathan M; Snehalatha C; Mohan V; Ramachandran A; Mohan R
    J Assoc Physicians India; 1990 Nov; 38(11):833-4. PubMed ID: 2152550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experiences in the treatment of diabetes with insulins of monocomponent (MC) and monospecies (MS) type].
    Andreani D; Iavicoli M; Colletti A; Menzinger G
    Folia Endocrinol; 1972 Dec; 25(6):516-39. PubMed ID: 4581824
    [No Abstract]   [Full Text] [Related]  

  • 7. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes.
    Hummel M; Durinovic-Bello I; Ziegler AG
    J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte proliferation as a test of the immune response to insulin in diabetics.
    Kurtz AB; Di Silvio L; Lydyard P
    Diabetes Res; 1985 Jul; 2(4):175-8. PubMed ID: 3910325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunologic studies with fully synthetic human insulin in patients with diabetes mellitus].
    Diem P; Teuscher A
    Schweiz Med Wochenschr; 1979 Dec; 109(46):1814-6. PubMed ID: 574664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferative responses to insulin antigens in diabetics and controls.
    Scheinin T; Groop L; Nikkilä E; Kontiainen S
    J Clin Lab Immunol; 1983 Jul; 11(3):135-41. PubMed ID: 6350591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunogenicity of insulin preparations.
    Chance RE; Root MA; Galloway JA
    Acta Endocrinol Suppl (Copenh); 1976; 205():185-98. PubMed ID: 793278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does insulin administration contribute to immune complex formation in diabetes?
    Campbell LV; Charlesworth JA; Pasterfield GV; Jenkins A; Pussell BA
    Clin Exp Immunol; 1984 Nov; 58(2):255-63. PubMed ID: 6388921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proceedings: Formation of anti-insulin antibodies IgG in diabetic patients treated with conventional insulin monocomposed or monospecific].
    Weber HU; Sourisseau D; Zahnd GR
    Helv Med Acta; 1974 May; 37(5-6):367. PubMed ID: 4410557
    [No Abstract]   [Full Text] [Related]  

  • 14. Cellular immune alterations associated with human insulin therapy.
    Eichner HL; Lauritano AA; Woertz LL; Selam JL; Gupta S; Charles MA
    Diabetes Res; 1988 Jul; 8(3):111-5. PubMed ID: 3067952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes mellitus and immunity.
    Mincu I; Cheţa D
    Med Interne; 1983; 21(4):257-66. PubMed ID: 6361973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-specific cellular and humoral immunity in diabetic patients].
    Durić D; Protić-Hlusica D; Ljaljević J; Vulević I; Nesović M
    Srp Arh Celok Lek; 1976; 104(3-4):209-18. PubMed ID: 1019731
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diabetes and immunology. II. Role of autoimmunity in the precipitation of diabetes].
    Ekoe JM; Albert J
    Sem Hop; 1983 Jun; 59(22):1705-7. PubMed ID: 6308796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin antibodies in diabetics receiving a single type of insulin.
    Mincu I; Cheţa D
    Med Interne; 1982; 20(1):9-13. PubMed ID: 6765628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunogenic properties of highly purified insulin preparations: The clinical importance of insulin-binding antibodies.
    Anderson OO
    Acta Endocrinol (Copenh); 1975 Apr; 78(4):723-35. PubMed ID: 1173962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans.
    Charles MA; Suzuki M; Waldeck N; Dodson LE; Slater L; Ong K; Kershnar A; Buckingham B; Golden M
    J Immunol; 1983 Mar; 130(3):1189-94. PubMed ID: 6337213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.